23948sdkhjf
Innehållet nedan modereras inte i förväg och omfattas därmed inte av webbplatsens utgivningsbevis.
Dela sida

Affibody AB

Affibody is a private clinical-stage Swedish biotech company focused on developing into an integrated biopharma company utilizing next generation biotherapeutics based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

The company operates a focused experimental medicine model and currently has three clinical stage programs. The first two are therapeutic programs that targets psoriasis, and B-cell driven autoimmune diseases respectively. The third program is a diagnostic imaging program that is directed primarily towards metastatic breast cancer.

Affibody has ongoing commercial relationships with several companies such as AbClon, Alexion, Biotest, Daewoong, Daiichi Sankyo, GE Healthcare, and Swedish Orphan Biovitrum.

Affibody AB is a holding of Patricia Industries.

Affibody AB
PAA02800
FE 533
105 69 Stockholm
Sverige
VAT nummer: SE5567145601
Hitta oss på

Kontaktpersoner

{{ contact.name }}
{{ contact.title }}
Ladda mer

Företagsportfölj

Ladda mer

Sänd till en kollega

0.047